Advanced solid tumors
Conditions
Interventions
None listed
Sponsors
Nextcure Inc.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Outcome results
None listed
A PHASE I FIRST-IN-HUMAN, OPEN-LABEL, MULTICENTER STUDYTO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ANTITUMOR ACTIVITY OF SIM0505 IN ADULT PARTICIPANTS WITH ADVANCED SOLID TUMORS
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: Sep 12, 2026